| 1 (108) | Hoffmann-La Roche Ltd, United States | USA |  |
| 2 (109) | Genentech Inc | USA | |
| 3 (120) | Sanofi, United States | USA | |
| 4 (176) | AstraZeneca, Sweden | SWE | |
| 5 (179) | Siemens AG, Germany | DEU | |
| 6 (225) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | |
| 7 (237) | Sanofi, France | FRA | |
| 8 (241) | Eli Lilly and Company, United States | USA | |
| 9 (270) | Johnson & Johnson, United States | USA | |
| 10 (298) | Novo Nordisk A/S | DNK | |
| 11 (310) | Medtronic Inc, USA | USA | |
| 12 (321) | Bristol-Myers Squibb Company, United States | USA | |
| 13 (323) | Bayer AG, Germany | DEU | |
| 14 (329) | GlaxoSmithKline, United Kingdom | GBR | |
| 15 (388) | Siemens Healthineers, Germany | DEU | |
| 16 (473) | Boehringer Ingelheim, USA | USA | |
| 17 (484) | Abbott Laboratories, United States | USA | |
| 18 (506) | Amgen, USA | USA | |
| 19 (552) | Merck & Co Inc, United States | USA | |
| 20 (565) | AstraZeneca, United States | USA | |
| 21 (578) | Boehringer Ingelheim GmbH Germany | DEU | |
| 22 (602) | AstraZeneca, United Kingdom | GBR | |
| 23 (611) | Janssen Biotech Inc | USA | |
| 24 (613) | Pfizer Inc, United States | USA | |
| 25 (624) | CaixaBank SA * | ESP | |
| 26 (762) | Siemens AG, USA | USA | |
| 27 (771) | Siemens Healthineers, USA | USA | |
| 28 (889) | Novartis, Switzerland | CHE | |
| 29 (954) | Daiichi Sankyo Co Ltd, Japan | JPN | |
| 30 (1003) | Bosch, Germany | DEU | |
| 31 (1060) | Boston Scientific Corp, USA | USA | |
| 32 (1098) | Novartis Pharmaceuticals, United States | USA | |
| 33 (1260) | Keralty * | COL | |
| 34 (2167) | GE Healthcare, United States | USA | |
| 35 (2306) | Grupo Jose de Mello * | PRT | |
|
